Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HB20

Introduced
7/14/25  

Caption

Providing for adult use of cannabis; regulating the personal use and possession of cannabis; establishing the Keystone Cannabis Authority; providing for powers and duties of the Keystone Cannabis Authority; establishing the Community Opportunity Fund; providing for social and economic equity, for regulation of cannabis business establishments, for enforcement and immunities, for laboratory testing, for advertising, marketing, packaging and labeling and for preparation, destruction and regulation of cannabis and cannabis-infused edible and nonedible products; imposing a sales tax and excise tax on cannabis and cannabis-infused edible and nonedible products; establishing the Cannabis Regulation Fund; providing for cannabis clean slate and for miscellaneous provisions; imposing penalties; consolidating provisions relating to the medical use of cannabis; transferring certain powers and duties of the Department of Health to the Keystone Cannabis Authority; and making repeals.

Summary

HB20 would legalize adult-use cannabis in Pennsylvania and create a comprehensive regulatory framework for cultivation, processing, testing, transport, sale, and possession. It establishes the Keystone Cannabis Authority as the primary regulator for both adult-use and medical cannabis, transfers medical cannabis oversight from the Department of Health to that authority, and sets rules for permits, background checks, product testing, advertising, packaging, labeling, inventory tracking, and enforcement. The bill also authorizes existing medical cannabis businesses to begin adult-use sales and cultivation on a dual-use basis, while creating new permit categories for microcultivation centers, warehousing/distribution, and additional dispensaries. The measure sets possession limits for adults 21 and older, decriminalizes specified personal possession and use, and prohibits public smoking and use in certain sensitive locations. It also creates a detailed framework for workplace rules, law enforcement immunities, and protections against discrimination in housing, child welfare, custody, medical care, and firearm ownership based solely on lawful cannabis use. For people under 21, the bill creates summary offenses and penalties for possession, purchase, use, or cultivation, while preserving medical cannabis access for qualified patients. A major feature of HB20 is its social equity structure. It creates an Office of Social Equity and a Community Opportunity Fund to provide grants, loans, fee waivers, technical assistance, and workforce support for applicants from disproportionately impacted areas, impacted families, minority-owned businesses, women-owned businesses, veteran-owned businesses, and other diverse businesses. The bill also requires labor peace agreements for many licensees, sets aside permit opportunities for social and economic equity applicants and smaller businesses, and directs a portion of cannabis tax revenue to community investment, public health, law enforcement, agriculture, and the General Fund. HB20 would also change Pennsylvania criminal law by expunging certain nonviolent cannabis-related convictions, allowing resentencing petitions in some cases, and reinstating related driving and licensing privileges where applicable. It repeals the existing Medical Marijuana Act and replaces it with a new Chapter 93 while preserving ongoing contracts, regulations, and actions taken under the prior law. The bill further authorizes financial institutions to serve cannabis businesses, makes cannabis-related contracts enforceable despite federal prohibition, and allows municipalities to regulate time, place, and manner of cannabis businesses but not to ban them outright. Because there is no committee transcript or vote history provided, there is no recorded public debate or roll-call sentiment in the materials supplied. Based on the bill text alone, the proposal appears broadly expansive and pro-legalization, with strong emphasis on regulation, public safety, and equity. The main likely points of contention are the scope of legalization, the creation of a new state authority, the tax structure, labor peace requirements, municipal zoning limits, and the extent of automatic benefits for existing medical operators versus new market entrants.

Impact

HB20 would substantially rewrite Pennsylvania’s cannabis laws by adding a new Title 35 cannabis framework, repealing the Medical Marijuana Act, and shifting regulatory authority to the Keystone Cannabis Authority. It would legalize adult-use cannabis for adults 21 and older, establish licensing and compliance rules for cannabis businesses, create new funds for regulation and community reinvestment, and direct the Department of Revenue to administer cannabis taxes. It would also amend criminal, licensing, employment, housing, and records-related consequences tied to cannabis use and possession, while preserving and consolidating the medical cannabis program under the new authority.

Sentiment

No committee discussion or vote record was provided, so there is no documented legislative sentiment in the supplied materials. From the bill text, the measure is clearly supportive of legalization and market regulation, with a strong policy emphasis on social equity, public health safeguards, and transition of existing medical operators into the adult-use market. The structure suggests an intent to balance commercial access with tight oversight, which may appeal to legalization supporters while drawing concern from opponents of expanded cannabis access or state-run regulation.

Contention

The most notable likely points of contention are the legalization of adult-use cannabis itself, the breadth of the Keystone Cannabis Authority’s powers, and the bill’s treatment of existing medical cannabis businesses versus new entrants. The bill gives current medical operators an early path to adult-use sales and cultivation, which could be criticized as favoring incumbents, while also reserving permits and financial assistance for social and economic equity applicants, which could be criticized by those who prefer a more open market. Other likely disputes include labor peace agreement mandates, municipal limits on local bans, tax rates and revenue distribution, expungement provisions, and the bill’s protections for lawful cannabis users in employment, custody, firearms, and housing contexts.

Companion Bills

No companion bills found.

Previously Filed As

PA HB1735

Providing for cannabis; regulating the personal use and possession of cannabis; establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for disproportionately impacted area, for regulation of cannabis business establishments, for enforcement and immunities, for laboratory testing, for advertising, marketing, packaging and labeling and for preparation, destruction and regulation of cannabis, edible and infused products; imposing a sales tax and excise tax on cannabis, edible and infused products; providing for cannabis clean slate and for miscellaneous provisions; imposing penalties; consolidating provisions relating to medical use of cannabis; transferring powers and duties of the Department of Health to the Cannabis Control Board; and making repeals.

PA SB120

Providing for cannabis; regulating the personal use and possession of cannabis; establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for disproportionately impacted area, for regulation of cannabis business establishments, for enforcement and immunities, for laboratory testing, for advertising, marketing, packaging and labeling and for preparation, destruction and regulation of cannabis, edible and infused products; imposing a sales tax and excise tax on cannabis, edible and infused products; establishing the Cannabis Regulation Fund; providing for cannabis clean slate and for miscellaneous provisions; imposing penalties; consolidating provisions relating to medical use of cannabis; transferring powers and duties of the Department of Health to the Cannabis Control Board; and making repeals.

PA AB2250

Cannabis: cannabinoids.

PA SB49

Establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for permits and for dispensing cannabis to patients and caregivers; and making repeals.

PA AB8

Cannabis: cannabinoids: industrial hemp.

PA HB51

Relative to hemp-derived cannabinoids and the definition of cannabis in therapeutic cannabis.

PA HB1763

Relating to repealing certain offenses and removing certain regulations relating to marihuana, cannabis, cannabinoids, synthetic cannabinoids, and paraphernalia.

PA SB1548

Relating to marijuana; prescribing an effective date.

PA SF2165

Medical cannabis combination business plant canopy increase to cultivate cannabis sold as medical cannabis flower or medical cannabinoid products provision

PA HF2426

Plant canopy that a medical cannabis combination business may use to cultivate cannabis that will be sold as medical cannabis flower or medical cannabinoid products increased.

Similar Bills

No similar bills found.